Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified highrisk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n=3424) - Harbeck, N; Kates, RE; Look, MP (Cancer Res, 2002)
et al.